GenapSys Inc., a Redwood City, Calif.-based company developing an accurate gene sequencer, raised up to $75M in funding.
Oxford Finance provided the financing.
The company intends to use the funds to scale its global presence.
Led by Founder and CEO Dr. Hesaam Esfanyarpour, GenapSys announced the launch of its gene sequencer in the Asia Pacific (APAC) region, including in Korea, Singapore, Japan, and the Chinese gene sequencing market, which is currently at the epicenter of the expanding Coronavirus outbreak. The company is expanding internationally with more than 25 distributorship deals signed.
In parallel with its rollout in the APAC region, GenapSys is actively looking to partner with local health agencies and researchers to arm researchers with access to the insight afforded by sequencing. With its sequencing technology, the company aims to help support the control and limit the spread of current and future outbreaks. The device can run off of a standard power source and is small enough to fit in the back of a truck or be deployed at hospitals, airports, and public transportation hubs for quick results on virus samples.